These results align with a growing body of evidence, including a recent meta-analysis [33], that supports the efficacy of lower-dose insulin (0.05 U/kg/h) in suppressing ketogenesis and lowering glucose while substantially reducing iatrogenic complications like hypoglycemia and hypokalemia. Here, INS is linked to Hypokalemia.